Compare StocksBRK-B vs CME

Berkshire Hathaway Inc. (BRK-B) vs CME Group Inc. (CME): Which Is the Better Buy in 2026?

As of 2026-06-19, BRK-B is undervalued at $489, with a DCF intrinsic value of $644 and a margin of safety of 24%. CME is overvalued at $246, with an intrinsic value of $218 and a margin of safety of -13%. Of the two, BRK-B has the wider margin of safety.

BRK-B
Berkshire Hathaway Inc.
$489.46
VS
CME
CME Group Inc.
$246.38

Rewards

BRK-B
  • Each dollar of retained earnings has created $3.95 of earning power — management is an exceptional capital allocator.
  • Net debt/EBITDA of -2.3x means the company holds more cash than debt — a net cash position.
CME
  • Gross margin of 100.0% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • CME Group Inc. scores 77/100 on the Economic Moat Score (Wide Moat), with margin stability as the strongest competitive dimension.
  • Free cash flow has grown at a 12.2% CAGR over the past 4 years, demonstrating strong earnings power growth.

Risks

BRK-B
  • FCF yield of 5.8% suggests reasonable valuation assuming continued moderate growth.
  • PEG ratio of 10.06 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
CME
  • PEG ratio of 4.59 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
  • Altman Z-Score of 0.53 places the company in the distress zone — financial patterns resemble those of companies that experienced bankruptcy.

Key Valuation Metrics

Learn more →
BRK-B
CME
Valuation
$61.23B
Free Cash Flow
$4.19B
5.80%
FCF Yield
4.71%
14.56
Trailing P/E
21.41
22.79
Forward P/E
19.07
Quality & Moat
4.96%
ROIC
12.25%
10.50%
ROE
15.92%
27.78%
Gross Margin
100.00%
10.06
PEG Ratio
4.59
Balance Sheet Safety
Net cash
Net Debt / Equity
0.05
N/A
Interest Coverage
N/A
-2.28
Net Debt / EBITDA
0.26
0.00%
Dividend Yield
1.99%
BRK-B: 5Ties: 1CME: 6
BRK-BCME

Historical Fundamentals

Learn more →
BRK-B

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

CME

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
BRK-B
$1.66
created per $1 retained over 3 years
Value Creator
Σ Retained
$252.19B
Δ Market Cap
+$417.89B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
CME
$526.78
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$71.5M
Δ Market Cap
+$37.66B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
BRK-B
24.0% Margin of Safety
Price is 24.0% below estimated fair value
Current Price: $489.46
Fair Value: $643.73
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
CME
12.9% Overvalued
Price is 12.9% above estimated fair value
Current Price: $246.38
Fair Value: $218.17
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
BRK-B

What growth rate is the market pricing in at $489?

+0.4%
Market-Implied Owner Earnings Growth
Standard FCF implies +1.6%

The market implies +0.4% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +1.6%, reflecting heavy growth investment.

CME

What growth rate is the market pricing in at $246?

+8.3%
Market-Implied Owner Earnings Growth
Standard FCF implies +8.7%

The market implies +8.3% Owner Earnings growth, below historical trends — potential opportunity.

Standard FCF implies a more demanding +8.7%, reflecting heavy growth investment expected to generate future returns.

Economic Moat Score

Learn more →
BRK-B
40/100
Narrow Moat
70+ Wide · 40-69 Narrow · <40 None

Narrow moat with reinvestment efficiency as the key competitive advantage. Improving revenue predictability would strengthen the moat.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
CME
77/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat driven primarily by margin stability. ROIC Consistency is the area most vulnerable to competitive pressure.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

Forensic Accounting

Learn more →
BRK-B
-2.41
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
CME
-2.43
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
BRK-B
Insiders 0.3%Institutions 67.3%Retail & Other 32.4%
No. of Institutional Holders5,905
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
CME
Insiders 0.4%Institutions 92.7%Retail & Other 6.9%
No. of Institutional Holders2,391
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
BRK-B
1
Buys (3M)
1
Buys (12M)
Total value (12M): $250,545
O'SULLIVAN MICHAEL J
General Counsel
$250,545
@ $467.43 · 2026-05-06
Open market purchases · includes direct & indirect ownership · excludes option exercises
CME
1
Buys (3M)
2
Buys (12M)
Total value (12M): $509,437
SHEPARD WILLIAM R
Director
$437,101
@ $297.55 · 2026-03-26
SHEPARD WILLIAM R
Director
$72,336
@ $270.92 · 2025-06-25
SHEPARD WILLIAM R
Director
$71,995
@ $262.76 · 2025-03-26
SHEPARD WILLIAM R
Director
$325,798
@ $227.99 · 2025-01-16
SHEPARD WILLIAM R
Director
$324,198
@ $227.99 · 2025-01-16
BENESH KATHRYN
Director
$3,595
@ $239.67 · 2024-12-27
SHEPARD WILLIAM R
Director
$63,945
@ $218.99 · 2024-09-25
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
BRK-B
0
Sells (3M)
0
Sells (12M)
No open market insider sales found.
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
CME
2
Sells (3M)
14
Sells (12M)
Total value (12M): $28.07M
PIELL HILDA HARRIS
Officer
$1.75M
@ $304.63 · 2026-05-18
DUFFY TERRENCE A
Chief Executive Officer
$10.45M
@ $298.51 · 2026-05-15
MARCUS JONATHAN L
General Counsel
$1.10M
@ $333.37 · 2026-03-17
MARCUS JONATHAN L
Officer
$1.03M
@ $313.37 · 2026-03-17
VROMAN KENDAL L
Officer
$1.59M
@ $309.00 · 2026-03-12
DURKIN BRYAN T
Director
$1.30M
@ $309.65 · 2026-02-23
GEPSMAN MARTIN J
Director
$91,770
@ $305.90 · 2026-02-20
SUSKIND DENNIS A
Director
$224,400
@ $300.00 · 2026-02-06
DUFFY TERRENCE A
Chief Executive Officer
$6.74M
@ $269.55 · 2025-12-11
FORD HAROLD EUGENE JR
Director
$263,530
@ $263.53 · 2025-11-03
MARCUS JONATHAN L
General Counsel
$102,704
@ $262.00 · 2025-09-18
MCCOURT TIMOTHY FRANCIS
Officer
$98,476
@ $259.83 · 2025-09-16
MARCUS JONATHAN L
General Counsel
$97,369
@ $258.96 · 2025-09-16
CUTINHO SUNIL KIRAN
Chief Technology Officer
$3.23M
@ $271.47 · 2025-08-26
KAYE DANIEL G
Director
$141,210
@ $282.42 · 2025-05-22
MARCUS JONATHAN L
General Counsel
$108,225
@ $277.50 · 2025-05-20
LOCKETT PHYLLIS M
Director
$294,553
@ $277.88 · 2025-05-19
GEPSMAN MARTIN J
Director
$81,951
@ $273.17 · 2025-05-15
SUSKIND DENNIS A
Director
$271,280
@ $271.28 · 2025-04-29
GERDES LARRY G
Director
$1.06M
@ $265.11 · 2025-04-25
LUCAS DEBORAH J
Director
$385,425
@ $256.95 · 2025-03-14
DUFFY TERRENCE A
Chief Executive Officer
$7.78M
@ $259.18 · 2025-03-11
SPRAGUE SUZANNE
Chief Operating Officer
$385,249
@ $256.83 · 2025-03-03
PIELL HILDA HARRIS
Officer
$997,853
@ $250.47 · 2025-02-27
WINKLER JULIE
Officer
$2.89M
@ $249.17 · 2025-02-13
VROMAN KENDAL L
Officer
$1.27M
@ $250.00 · 2025-02-13
GEPSMAN MARTIN J
Director
$89,168
@ $222.92 · 2024-11-04
CUTINHO SUNIL KIRAN
Chief Technology Officer
$1.02M
@ $226.64 · 2024-10-30
BITSBERGER TIMOTHY S
Director
$226,957
@ $226.96 · 2024-10-30
MCCOURT TIMOTHY FRANCIS
Officer
$312,056
@ $227.11 · 2024-10-28
FITZPATRICK LYNNE
Chief Financial Officer
$163,610
@ $216.99 · 2024-09-13
DURKIN BRYAN T
Director
$1.63M
@ $214.59 · 2024-08-30
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
BRK-B
FearGreed
😏Greed(65/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
CME
FearGreed
😨Fear(32/100)

"Market is pessimistic — investigate whether fears are temporary or structural"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
BRK-B
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (65)
CME
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Fear (32)
View BRK-B Full AnalysisView CME Full Analysis

Frequently Asked Questions: BRK-B vs CME

Is Berkshire Hathaway Inc. or CME Group Inc. more undervalued in 2026?

Based on our discounted cash flow model, BRK-B trades at a 24.0% margin of safety (intrinsic value $644 vs. price $489), compared to CME's -12.9% margin of safety (intrinsic $218 vs. $246).

Which stock has a wider economic moat, Berkshire Hathaway Inc. or CME Group Inc.?

CME scores 77/100 (Wide moat), while BRK-B scores 40/100 (Narrow moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is CME Group Inc. in financial distress?

CME's Altman Z-Score of 0.5 places it in the Distress zone, signaling elevated bankruptcy risk. BRK-B scores 2.5 (Grey zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which company has better free cash flow, Berkshire Hathaway Inc. or CME Group Inc.?

Berkshire Hathaway Inc. (BRK-B) generates a 5.8% free cash flow yield, compared to CME Group Inc.'s 4.7%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

Which stock has higher return on invested capital, Berkshire Hathaway Inc. or CME Group Inc.?

CME earns 12.2% ROIC versus BRK-B's 5.0%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.